The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000527.5(LDLR):c.44T>C (p.Leu15Pro)

CA10584732

250981 (ClinVar)

Gene: LDLR (HGNC:3949)
Condition: hypercholesterolemia, familial (MONDO:0007750)
Inheritance Mode: Semidominant inheritance
UUID: 5a4acf2a-a4d4-4d21-b7ac-83ea18a248e0
Approved on: 2022-08-28
Published on: 2022-08-28

HGVS expressions

NM_000527.5:c.44T>C
NM_000527.5(LDLR):c.44T>C (p.Leu15Pro)
NC_000019.10:g.11089592T>C
CM000681.2:g.11089592T>C
NC_000019.9:g.11200268T>C
CM000681.1:g.11200268T>C
NC_000019.8:g.11061268T>C
NG_009060.1:g.5212T>C
ENST00000558518.6:c.44T>C
ENST00000455727.6:c.44T>C
ENST00000535915.5:c.44T>C
ENST00000545707.5:c.44T>C
ENST00000557933.5:c.44T>C
ENST00000557958.1:n.130T>C
ENST00000558013.5:c.44T>C
ENST00000558518.5:c.44T>C
ENST00000560502.5:n.130T>C
NM_000527.4:c.44T>C
NM_001195798.1:c.44T>C
NM_001195799.1:c.44T>C
NM_001195800.1:c.44T>C
NM_001195803.1:c.44T>C
NM_001195798.2:c.44T>C
NM_001195799.2:c.44T>C
NM_001195800.2:c.44T>C
NM_001195803.2:c.44T>C
NR_163945.1:n.68A>G
More

Likely Pathogenic

Met criteria codes 4
PS4_Supporting PS3_Moderate PP4 PM2
Not Met criteria codes 22
BA1 BP5 BP7 BP2 BP3 BP4 BP1 BS4 BS3 BS1 BS2 PVS1 PP1 PP3 PP2 PS2 PS1 PM3 PM1 PM4 PM5 PM6

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.44T>C (p.Leu15Pro) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying evidence codes PM2, PS3_Moderate, PP4, and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: PM2 - This variant is absent from gnomAD (gnomAD v2.1.1), so PM2 is met. PS3_moderate - Level 2 Assay: PMID:27175606: Heterologous cells (CHO), CLSM assays: LDLR retained in ER, no LDL-LDLR binding. LDL binding <70% wild type activity, so PS3_Moderate is met. PS4_supporting - Variant meets PM2 and is identified in - 2 unrelated index cases who fulfill Simon-Broome possible criteria for FH from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies (APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière), - 1 case from PMID: 12052488 with LDL-C above 10 mmol/L (DLCN>6), from Sweden. 3 cases, so PS4_Supporting is met. PP4 - Variant meets PM2 and is identified in 3 unrelated index cases who fulfill FH clinical criteria (see PS4 for details).
Met criteria codes
PS4_Supporting
Variant meets PM2 and is identified in - 2 unrelated index cases who fulfill Simon-Broome possible criteria for FH from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies (APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière), - 1 case from PMID: 12052488 with LDL-C above 10 mmol/L (DLCN>6), from Sweden. 3 cases, so PS4_Supporting is met
PS3_Moderate
Level 2 Assay: PMID:27175606 Heterologous cells (CHO), CLSM assays: LDLR retained in ER, no LDL-LDLR binding LDL binding <70% wild type activity, so PS3_Moderate is met
PP4
Variant meets PM2 and is identified in - 2 unrelated index cases who fulfill Simon-Broome possible criteria for FH from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies (APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière), - 1 case from PMID: 12052488 with LDL-C above 10 mmol/L (DLCN>6), from Sweden. so PP4 is met
PM2
This variant is absent from gnomAD (gnomAD v2.1.1), so PM2 is met.
Not Met criteria codes
BA1
This variant is absent from gnomAD (gnomAD v2.1.1)
BP5
not applicable
BP7
variant is missense, so not applicable
BP2
no index cases with other variants were identified
BP3
not applicable
BP4
REVEL = 0.675. It is not below 0.50, so BP4 is not met
BP1
not applicable
BS4
there is no segregation data
BS3
Level 2 Assay: PMID:27175606 Heterologous cells (CHO), CLSM assays: LDLR retained in ER, no LDL-LDLR binding LDL binding <70% wild type activity, so BS3 is not met
BS1
This variant is absent from gnomAD (gnomAD v2.1.1)
BS2
there is no data on normolipidemic individuals, so not met
PVS1
variant is missense and not in initiation codon, so not met
PP1
there is no segregation data
PP3
REVEL = 0.675. It is not above 0.75, so PP3 is not met
PP2
not applicable
PS2
no de novo occurrence was identified
PS1
There is no other missense variant that leads to the same amino acid change, so not met
PM3
no index cases with other variants were identified
PM1
variant is missense and meets PM2, but it is in exon 1 and does not alter Cys, so not met
PM4
variant is missense, so not applicable
PM5
there is 1 more missense variant in the same codon: NM_000527.5(LDLR):c.44T>A (p.Leu15His) (ClinVar ID 250980) - classified as VUS by these guidelines, so PM5 is not met
PM6
no de novo occurrence was identified
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.